Anojan Navaratnam
WinnMed, Mayo Clinic in Florida, Mayo Clinic Hospital, Royal Brisbane and Women's Hospital
Papers
11
Total Citations
231
H-Index
8
About
Dr. Anojan Navaratnam is a pioneering urologic surgeon whose work has fundamentally advanced the application of robotic technology in complex oncologic procedures. His research focuses on robot-assisted surgery for high-stakes urologic cancers, particularly radical cystectomy, nephrectomy with inferior vena cava (IVC) tumor thrombectomy, and retroperitoneal lymph node dissection (RPLND) for testicular cancer. A major contribution is his comparative effectiveness research, including a landmark Mayo Clinic study (40 citations) demonstrating the safety and efficacy of robot-assisted nephrectomy for level I and II IVC tumor thrombi, challenging the traditional open approach. His decade-long analysis of robot-assisted versus open cystectomy (39 citations) provides crucial evidence supporting robotic outcomes. Dr. Navaratnam has also shaped surgical technique, notably showing that intracorporeal urinary diversion reduces benign ureteroenteric stricture rates (20 citations). His multi-institutional work on post-chemotherapy RPLND (21 citations) and his comprehensive review of robotic IVC surgery (20 citations) have established best practices for these demanding procedures. With over 200 total citations, Dr. Navaratnam’s work is essential reading for surgeons seeking to expand the boundaries of minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1Updates in Urologic Robot Assisted Surgery52 citations · 2018
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10